24-hydroxycholesterol has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bergsland, N; Browne, RW; Dunne-Jaffe, C; Dwyer, MG; Jakimovski, D; Pelizzari, L; Ramanathan, M; Weinstock-Guttman, B; Zivadinov, R | 1 |
| Axelsson, M; Björkhem, I; Karrenbauer, VD; Lycke, J; Malmeström, C; Novakova, L; Zetterberg, H | 1 |
| Björkhem, I; Davies, G; Giovannoni, G; Ingle, GT; Karrenbauer, VD; Leoni, V; Lim, ET; Masterman, T; Miller, DH; Rashid, W; Sastre-Garriga, J; Thompson, AJ | 1 |
3 other study(ies) available for 24-hydroxycholesterol and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis.
Topics: Carotid Artery, Common; Humans; Hydroxycholesterols; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxysterols; Recurrence | 2022 |
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Topics: Adolescent; Adult; Biomarkers; Female; Humans; Hydroxycholesterols; Immunologic Factors; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Treatment Outcome; Young Adult | 2015 |
Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.
Topics: Adult; Brain; Cholesterol; Female; Humans; Hydroxycholesterols; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Plasma; Sampling Studies | 2006 |